DTC Telehealth Partnerships: Navigating Risks in Pharma’s Digital Expansion

By Staff Writer

July 18, 2025

The “DTC Investigation 2025” report by U.S. Senators Durbin, Sanders, Warren, and Welch highlights the emergence of DTC telehealth partnerships. These partnerships form between pharmaceutical companies, specifically Pfizer and Eli Lilly, and telehealth providers to market high-cost prescription m...
MAF Test Breast Cancer: Revolutionizing Personalized Treatment in Spanish Oncology

By João L. Carapinha

July 17, 2025

A recent announcement by IRB Barcelona details the integration of the MAF Test breast cancer into several leading Spanish hospitals, including Hospital del Mar and the Clínic Barcelona Comprehensive Cancer Center. This molecular assay helps oncologists stratify early-stage breast cancer patients ...
NICE’s Ribociclib Breast Cancer Guidance: A New Era for High-Risk Patients in the NHS
NICE has recently released final draft guidance recommending the use of ribociclib breast cancer guidance, specifically in combination with an aromatase inhibitor for adjuvant treatment in adults with hormone receptor-positive, HER2-negative early breast cancer at high risk of recurrence. The gui...
Efficacy and Insights of Transdiagnostic Mental Health Apps for Depression and Anxiety

By Staff Writer

July 16, 2025

Transdiagnostic mental health apps are digital interventions designed to target shared mechanisms underlying depression, anxiety, and related distress. Do these apps actually help users improve their mental health outcomes, especially compared to disorder-specific solutions? Recent meta-analytic ...
National Bulk Purchasing Strategy: Enhancing Drug Affordability and Access in Canada
A national bulk purchasing strategy is emerging as a crucial solution for Canada’s prescription drug system. How could this approach impact affordability, access, and the long-term stability of pharmacare in Canada? Canada’s Drug Agency (CDA) has initiated a national consultation to develop advic...
Elderly Care Costs 2025: Rising Financial Pressures in Dutch Health Services

By João L. Carapinha

July 15, 2025

A recent article from Zorginstituut Nederland reports that elderly care costs in 2025 are expected to rise significantly in the Netherlands. The announcement highlights the increasing financial pressures on the Dutch health system. Demographic shifts and greater demand for complex, long-term care...

Search By Category

Latest

DTC Telehealth Partnerships: Navigating Risks in Pharma’s Digital Expansion

By Staff Writer

July 18, 2025

The “DTC Investigation 2025” report by U.S. Senators Durbin, Sanders, Warren, and Welch highlights the emergence of DTC telehealth partnerships. These partnerships form between pharmaceutical companies, specifically Pfizer and Eli Lilly, and telehealth providers to market high-cost prescription m...

Latest

MAF Test Breast Cancer: Revolutionizing Personalized Treatment in Spanish Oncology

By João L. Carapinha

July 17, 2025

A recent announcement by IRB Barcelona details the integration of the MAF Test breast cancer into several leading Spanish hospitals, including Hospital del Mar and the Clínic Barcelona Comprehensive Cancer Center. This molecular assay helps oncologists stratify early-stage breast cancer patients ...

Latest

NICE’s Ribociclib Breast Cancer Guidance: A New Era for High-Risk Patients in the NHS
NICE has recently released final draft guidance recommending the use of ribociclib breast cancer guidance, specifically in combination with an aromatase inhibitor for adjuvant treatment in adults with hormone receptor-positive, HER2-negative early breast cancer at high risk of recurrence. The gui...

Latest

Efficacy and Insights of Transdiagnostic Mental Health Apps for Depression and Anxiety

By Staff Writer

July 16, 2025

Transdiagnostic mental health apps are digital interventions designed to target shared mechanisms underlying depression, anxiety, and related distress. Do these apps actually help users improve their mental health outcomes, especially compared to disorder-specific solutions? Recent meta-analytic ...

Global Updates

DTC Telehealth Partnerships: Navigating Risks in Pharma’s Digital Expansion

By Staff Writer

July 18, 2025

The “DTC Investigation 2025” report by U.S. Senators Durbin, Sanders, Warren, and Welch highlights the emergence of DTC telehealth partnerships. These partnerships form between pharmaceutical companies, specifically Pfizer and Eli Lilly, and telehealth providers to market high-cost prescription m...

Global Updates

Efficacy and Insights of Transdiagnostic Mental Health Apps for Depression and Anxiety

By Staff Writer

July 16, 2025

Transdiagnostic mental health apps are digital interventions designed to target shared mechanisms underlying depression, anxiety, and related distress. Do these apps actually help users improve their mental health outcomes, especially compared to disorder-specific solutions? Recent meta-analytic ...

Global Updates

National Bulk Purchasing Strategy: Enhancing Drug Affordability and Access in Canada
A national bulk purchasing strategy is emerging as a crucial solution for Canada’s prescription drug system. How could this approach impact affordability, access, and the long-term stability of pharmacare in Canada? Canada’s Drug Agency (CDA) has initiated a national consultation to develop advic...

Global Updates

Silencing Science Impact: Political Interference and Global Health Consequences

By João L. Carapinha

July 15, 2025

The article “Global cost of silencing science” published by The BMJ argues that recent political interventions in the US—specifically under the Trump administration—are eroding the independence of scientific institutions. This has detrimental consequences for global scientific discourse,...

Europe

MAF Test breast cancer
       

MAF Test Breast Cancer: Revolutionizing Personalized Treatment in Spanish Oncology

🌟 How can personalized medicine transform breast cancer treatment in Spain?

The recent rollout of the MAF Test breast cancer in leading Spanish hospitals is set to revolutionize patient care by enabling targeted treatment strategies. This innovative molecular assay not only identifies patients who will benefit from bisphosphonates but also spares those for whom the treatment may be harmful, ultimately improving outcomes for thousands.

Dive into the article to discover how this approach aligns with global trends in oncology and enhances healthcare resource allocation.

#SyenzaNews #precisionmedicine #HealthEconomics #innovation

Middle East

publication delays impact careers
     

Publication Delays Impact Careers of Early-Career Researchers

🚨 Publication delays are derailing academic careers!

In an insightful piece, “Dear editors, your publication delays are damaging our careers,” Chia-Hsuan Hsu reveals how prolonged editorial and peer-review processes are stifling early-career researchers, particularly in East Asia. With a focus on the systemic inefficiencies in academic publishing, the article discusses the urgent need for reform to protect researchers from the detrimental impacts of such delays.

Jump into the full article to uncover the challenges faced and explore proactive solutions for a more efficient publishing landscape. 📚✨

#SyenzaNews #HealthEconomics #HealthcarePolicy

Sub-Saharan Africa

lenacapavir HIV prevention
           

Lenacapavir HIV Prevention: Gilead’s Strategic Agreement to Enhance Access in Low-Income Countries

🌍 What if a twice-yearly injectable could transform HIV prevention in low-income regions?

Gilead’s new partnership with the Global Fund aims to provide lenacapavir—an innovative injectable for HIV prevention—at no profit, reaching up to two million individuals in low- and lower-middle-income countries. This groundbreaking initiative not only addresses critical access barriers but also sets a precedent for how public-private partnerships can enhance health equity.

Dive into the details of this pivotal collaboration and its implications for global health.

#SyenzaNews #globalhealth #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.